Abstract
BACKGROUND & AIMS: In the American Gastroenterological Association/American Association for the Study of Liver Diseases (AGA/AASLD) Clinical Care Pathway, Fibrosis-4 index (FIB-4) is used to stratify patients at risk for metabolic dysfunction-associated steatotic liver disease (MASLD) as low-, indeterminate-, or high-risk for developing advanced liver fibrosis. We assessed the performance of FIB-4 in a general population.
METHODS: Using the 2017 to 2020 National Health and Nutrition Examination Surveys dataset, we selected subjects ≥18 years who had FibroScan data. We followed AGA/AASLD guidelines to identify subjects with characteristics that place them at risk for MASLD-associated liver fibrosis. Other causes of liver disease were excluded. Our final cohort had 3741 subjects. We then categorized these subjects based on recommended FIB-4 cutoffs. FibroScan liver stiffness measurement (LSM) served as the outcome measurement.
RESULTS: Among the 2776 subjects (74.2%) classified as low risk by FIB-4, 277 subjects (10%) were not classified at low risk by LSM, and 75 subjects (2.7%) were classified as high risk by LSM. Among the 86 subjects classified as high risk by FIB-4, 68 subjects (79.1%) were not at high risk by LSM, and 54 subjects (62.8%) were at low risk by LSM. Subjects misclassified by FIB-4 as low risk were older; had a higher body mass index, waist circumference, glycohemoglobin A1c level, alanine transaminase, aspartate transaminase, diastolic blood pressure, controlled attenuation parameter score, white blood cell count, alkaline phosphatase, and fasting glucose level; but had lower high-density lipoprotein, and albumin level (all P < .05). Misclassified subjects were also more likely to have prediabetes/diabetes.
CONCLUSION: Using FIB-4 in the AGA/AASLD guidelines to risk-stratify subjects at risk for MASLD-associated fibrosis results in many subjects being misclassified into the low- and high-risk categories. Therefore, it may be worthwhile considering caution in interpretation and/or alternative strategies.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1453-1461.e2 |
| Journal | Clinical Gastroenterology and Hepatology |
| Volume | 22 |
| Issue number | 7 |
| Early online date | Feb 29 2024 |
| DOIs | |
| State | Published - Jul 2024 |
Keywords
- MASH
- NASH
- Noninvasive Test
- Steatosis
- Severity of Illness Index
- Nutrition Surveys
- Elasticity Imaging Techniques/methods
- Liver Cirrhosis/diagnostic imaging
- United States
- Humans
- Middle Aged
- Male
- Fatty Liver/diagnostic imaging
- Female
- Adult
- Risk Assessment/methods
- Aged
- Liver/diagnostic imaging
- Practice Guidelines as Topic
- Cohort Studies
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Divisions
- Abdominal Transplant
- Gastroenterology and Hepatology
Fingerprint
Dive into the research topics of 'Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS